Factor VII is one of the clotting factors involved in the coagulation cascade that produces blood clotting. Recombinant factor VII is synthesized and produces the same effects as that which is plasma-derived. It is primarily used for prevention and control of hemorrhage in individuals with factor VII deficiency. Recombinant factor VII has been evaluated in patients with cancer for prevention and control of bleeding.